Login / Signup

A survey of Australian psychiatrists' and psychiatry trainees' knowledge of and attitudes towards psychedelics in the treatment of psychiatric disorders.

Cameron J GroverLauren MondsMark E Montebello
Published in: Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists (2023)
The poor response rate was a major limitation of this study. Our sample of Australian psychiatrists and trainees were enthusiastic about psychedelics as psychiatric treatment and were aware of some of the evidence demonstrating their efficacy. Safety continues to be a concern, despite growing evidence of their safety in therapeutic settings. Education about the evidence of their efficacy and the risks associated with their use is needed.
Keyphrases
  • healthcare
  • primary care
  • general practice
  • risk assessment
  • quality improvement
  • human health